glp-1 cv outcome trials BJD GLP-1 receptor agonists were developed

A recent randomized clinical trial from Denmark evaluated weight loss maintenance after one of four 52-week regimens (placebo, once daily liraglutide 3.0 mg alone, supervised exercise alone, or liraglutide plus supervised exercise) in 109 adults with obesity without serious chronic illnesses, including diabetes

This program supports members at every stage of their journeywhether theyre navigating menopause, using GLP-1 weight-loss medications, or simply looking to build sustainable movement into a healthier lifestyle

R.D'AlessioD.DruckerD

Whilst not approved specifically as antihypertensive agents in the UK, these medications may reduce systolic blood pressure by approximately 24 mmHg alongside their metabolic benefits

Receive compounded semaglutide or tirzepatide

Very easy to understand and helpful. Dan Dolores was very knowledgeable and very friendly she answered any questions I had